We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Final Guidance on Controlled Correspondence for Generics
FDA Issues Final Guidance on Controlled Correspondence for Generics
The FDA has issued final guidance for generics makers on making formal requests for information, including on topics that are still under agency consideration.